循環器内科 Twitter アカウントlanguage English

英文総説　Review Papers in English


＞2023　＞2022　＞2021　＞2020
＞＞2010～2019　
＞＞2005～2009　

緑色のタイトル部分をクリックすると、総説PDFが表示されます。

【 2024 年 】（IF: 2022 年）

  1. Shimokawa H. Therapeutic potentials of sound waves in cardiovascular medicine: further important evidence. Eur Heart J. (in press) (IF=39.3)

【 2023 年 】（IF: 2022 年）

  1. Shimokawa H. Roles of endothelial and smooth muscle cell dysfunction and vasa vasorum in vasomotor disorders in ischemia with no obstructive coronary artery disease. Vasc Pharmacol. 2023 Sep 21:107234. doi: 10.1016/j.vph.2023.107234. (IF=5.7)

  2. Kaski JC, Shimokawa H. Coronary artery spasm –A special focus issue. Eur Cardiol Rev. 2023;2:e53. DOI: 10.15420/ecr.2023.11 (IF=3.0)

  3. Ohyama-Tamagake A, Kaneko K, Itami R, Nakano M, Namioka Y, Izumi R, Sato H, Suzuki H, Takeda A, Okazaki Y, Yatsuka Y, Abe T, Murayama K, Sugeno N, Misu T and Aoki M. Reply to the Letter "Reversible vasoconstriction syndrome is a complication of SARS-CoV-2 infection/vaccination rather than that of Leigh syndrome". Internal Medicine 2023 DOI: 10.2169/internalmedicine.1962-23 (EPUB)(IF=1.2)

  4. Hokimoto S, Kaikita K, Yasuda S, Tsujita K, Ishihara M, Matoba T, Matsuzawa Y, Mitsutake Y, Mitani Y, Murohara T, Noda T, Node K, Noguchi T, Suzuki H, Takahashi J, Tanabe Y, Tanaka A, Tanaka N, Teragawa H, Yasu T, Yoshimura M, Asaumi Y, Godo S, Ikenaga H, Imanaka T, Ishibashi K, Ishii M, Ishihara T, Matsuura Y, Miura H, Nakano Y, Ogawa T, Shiroto T, Soejima H, Takagi R, Tanaka A, Tanaka A, Taruya A, Tsuda E, Wakabayashi K, Yokoi K, Minamino T, Nakagawa Y, Sueda S, Shimokawa H and Ogawa H. JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction. Circ J. 87;879-936, 2023. DOI: 10.1253/circj.CJ-22-0779. (IF=3.3)

  5. Godo S, Yasuda S. New landscape of acute myocardial infarction complicated by cardiogenic shock with the advent of a small but mighty heart pump. Circ J. 2023;87:598-599. (IF=3.3)

  6. Nishimiya N, Takahashi J, Oyama K, Matsumoto Y, Yasuda S, Shimokawa H. Mechanisms of coronary artery spasm. Eur Cardiol Rev. 2023;2:e39. DOI: 10.15420/ecr.2022.55 （IF=3.0）

  7. Godo S, Takahashi J, Shiroto T, Yasuda S, Shimokawa H. Coronary microvascular spasm: clinical presentations and diagnosis. Eur Cardiol Rev. 2023;18:e07. DOI: 10.15420/ecr.2022.50 (IF=3.0)

  8. Lanza GA, Shimokawa H. Management of coronary artery spasm. Eur Cardiol Rev. 2023;18:e38. DOI: 10.15420/ecr.2022.47 (IF=3.0)

【 2022 年 】（IF: 2021 年）

  1. Nochioka K. Is Intravenously Administered Tolvaptan Mighty Like Triton? Circ J. 2022 May 11. doi: 10.1253/circj.CJ-22-0194. Online ahead of print.(IF=3.350)

  2. Masato Nakamura, Hitoshi Yaku, Junya Ako, Hirokuni Arai, Tohru Asai, Taishiro Chikamori, Hiroyuki Daida, Kiyoshi Doi, Toshihiro Fukui, Toshiaki Ito, Kazushige Kadota, Junjiro Kobayashi, Tatsuhiko Komiya, Ken Kozuma, Yoshihisa Nakagawa, Koichi Nakao, Hiroshi Niinami, Takayuki Ohno, Yukio Ozaki, Masataka Sata, Shuichiro Takanashi, Hirofumi Takemura, Takafumi Ueno, Satoshi Yasuda, Hitoshi Yokoyama, Tomoyuki Fujita, Tokuo Kasai, Shun Kohsaka, Takashi Kubo, Susumu Manabe, Naoya Matsumoto, Shigeru Miyagawa, Tomohiro Mizuno, Noboru Motomura, Satoshi Numata, Hiroyuki Nakajima, Hirotaka Oda, Hiromasa Otake, Fumiyuki Otsuka, Ken-ichiro Sasaki, Kazunori Shimada, Tomoki Shimokawa, Toshiro Shinke, Tomoaki Suzuki, Masao Takahashi, Nobuhiro Tanaka, Hiroshi Tsuneyoshi, Taiki Tojo, Dai Une, Satoru Wakasa, Koji Yamaguchi, Takashi Akasaka, Atsushi Hirayama, Kazuo Kimura, Takeshi Kimura, Yoshiro Matsui, Shunichi Miyazaki, Yoshitaka Okamura, Minoru Ono, Hiroki Shiomi, Kazuo Tanemoto, on behalf of the Japanese Circulation Society Joint Working Group. JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease. Circ J. 2022 Mar Vol.86 No.3 477-588.(IF=3.350)

【 2021 年 】（IF: 2020 年）

  1. Godo S, Takahashi J, Yasuda S, Shimokawa H. Endothelium in coronary macro - and microvascular diseases.
    J Cardiovasc Pharmacol. 78:S19-S29, 2021. doi: 10.1097/FJC.0000000000001089.(IF=3.105)

  2. Takahashi J, Shimokawa H, Yasuda S. Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques. Int J Cardiol. 2021 Oct 20:S0167-5273(21)01577-1. doi: 10.1016/j.ijcard.2021.10.023. Online ahead of print. (IF=4.164)

  3. Shimokawa H. The 2020 Olympic/Paralympic Games and Covid-19 in Japan. Eur Heart J. 42(38):3895-3896,2021. doi:10.1093/eurheartj/ehab543 (IF=29.983)

  4. Takahashi J, Suda A, Nishimiya K, Godo S, Yasuda S, Shimokawa H. Pathophysiology and diagnosis of coronary functional abnormalities. Eur Cardiol Rev. 2021;16:e30. DOI: 10.15420/ecr.2021.23

  5. Anzai T, Sato T, Fukumoto Y, Izumi C, Kizawa Y, Koga M, Nishimura K, Ohishi M, Sakashita A, Sakata Y, Shiga T, Takeishi Y, Yasuda S, Yamamoto K, Abe T, Akaho R, Hamatani Y, Hosoda H, Ishimori N, Kato M, Kinugasa Y, Kubozono T, Nagai T, Oishi S, Okada K, Shibata T, Suzuki A, Suzuki T, Takagi M, Takada Y, Tsuruga K, Yoshihisa A, Yumino D, Fukuda K, Kihara Y, Saito Y, Sawa Y, Tsutsui H, Kimura T; Japanese Circulation Society Joint Working Group. JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases. Circ J. 2021 Mar 26. doi: 10.1253/circj.CJ-20-1127. Online ahead of print. (IF=2.993)

  6. Yamagishi M, Tamaki N, Akasaka T, Ikeda T, Ueshima K, Uemura S, Otsuji Y, Kihara Y, Kimura K, Kimura T, Kusama Y, Kumita S, Sakuma H, Jinzaki M, Daida H, Takeishi Y, Tada H, Chikamori T, Tsujita K, Teraoka K, Nakajima K, Nakata T, Nakatani S, Nogami A, Node K, Nohara A, Hirayama A, Funabashi N, Miura M, Mochizuki T, Yokoi H, Yoshioka K, Watanabe M, Asanuma T, Ishikawa Y, Ohara T, Kaikita K, Kasai T, Kato E, Kamiyama H, Kawashiri M, Kiso K, Kitagawa K, Kido T, Kinoshita T, Kiriyama T, Kume T, Kurata A, Kurisu S, Kosuge M, Kodani E, Sato A, Shiono Y, Shiomi H, Taki J, Takeuchi M, Tanaka A, Tanaka N, Tanaka R, Nakahashi T, Nakahara T, Nomura A, Hashimoto A, Hayashi K, Higashi M, Hiro T, Fukamachi D, Matsuo H, Matsumoto N, Miyauchi K, Miyagawa M, Yamada Y, Yoshinaga K, Wada H, Watanabe T, Ozaki Y, Kohsaka S, Shimizu W, Yasuda S, Yoshino H; Japanese Circulation Society Working Group. JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases. Circ J. 2021 Mar 25;85(4):402-572. doi: 10.1253/circj.CJ-19-1131. Epub 2021 Feb 16. (IF=2.993)

  7. Godo S, Suda A, Takahashi J, Yasuda S, Shimokawa H. Coronary microvascular dysfunction. Arterioscler Thromb Vasc Biol. 2021;41:1625-1637. doi: 10.1161/ATVBAHA.121.316025. (IF=8.311)

  8. Godo S, Takahashi J, Yasuda S, Shimokawa H. The role of inflammation in coronary epicardial and microvascular dysfunction. Eur Cardiol Rev. 2021;16:e13. DOI:10.15420/ecr.2020.47

  9. Suzuki H, Yasuda S, Shimokawa H. Brain-heart connection in Takotsubo syndrome "before" the onset. Eur Heart J. 2021 Feb 3;ehab026. doi: 10.1093/eurheartj/ehab026. Online ahead of print. (IF=29.983)

  10. Nishimiya K, Shimokawa H. Gender differences in coronary functional abnormalities. Italian J Gender-specific Med. 7:15-21,2021.

【 2020 年 】（IF: 2019 年）

  1. Godo S, Shimokawa H. Gender differences in endothelial function and coronary vasomotion abnormalities. Gender and the Genome. 4:1-11,2020.

  2. Nishimiya K, Matsumoto Y, Shimokawa H. Recent advances in vascular imaging. Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):e313-e321. doi: 10.1161/ATVBAHA.120.313609. Epub 2020 Oct 15.(IF=6.604)

  3. Shindo T, Shimokawa H. Therapeutic angiogenesis with sound waves. Ann Vasc Dis. 13:116-125,2020.

  4. Camici PG, Merz NB, Beltrame J, Brown D, Crea F, Kaski JC, Maas A, Ong P, Pepine C, Rimoldi O, Sechtem U, Shimokawa H, Elias-Smale S, Berry C. Commentary - The ISCHEMIA trial. Int J Cardiol. 304:1-6,2020. (IF=3.229)

  5. Merz CNB, Pepine CJ, Shimokawa H, Berry C. Treatment of coronary microvascular dysfunction. Cardiovasc Res. 116:856-870,2020. (IF=8.168）

  6. Sechtem U, Brown D, Godo S, Lanza GA, Shimokawa H, Sidik N. Coronary microvascular dysfunction in stable ischaemic heart disease (NOCAD and OCAD). Cardiovasc Res. 116:771-786,2020. (IF=8.168)

  7. Satoh K, Kikuchi N, Shimokawa H. PIM1 (provirus integration site for moloney murine leukemia virus) as a novel biomarker and therapeutic target in pulmonary arterial hypertension: another evidence for cancer theory. Arterioscler Thromb Vasc Biol. 40:500-502,2020. (IF=6.604)

  8. Ford TJ, Ong P, Sechtem U, Beltrame J, Camici PG, Crea F, Kaski JC, Merz CNB, Pepine CJ, Shimokawa H, Berry C. Assessment of vascular dysfunction in patients without obstructive coronary disease: why, how and when. JACC Cardiovasc Interv. 13:1847-1864,2020. (IF=8.432)

  9. Shimokawa H. Reactive oxygen species in cardiovascular health and disease -Special references to nitric oxide, hydrogen peroxide, and Rho-kinase- J Clin Biochem Nutr. 66:83-91,2020. (IF=2.405)（日本酸化ストレス学会学会賞受賞記念総説）